. 2018 Feb 23;24(4):849–860. doi: 10.1093/ibd/izx067
© 2018 Crohn’s & Colitis Foundation. Published by Oxford University Press on behalf of Crohn’s & Colitis Foundation.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/about_us/legal/notices)
FIGURE 1.
Flow chart of patients included in the vedolizumab study.